SC 13G: Apyx Medical Corp

AI Summary

SC 13G filing by Apyx Medical Corp.

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.001 — ration (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securitie

Filing Documents

• sc13g14118002_10312024.htm (SC 13G) — 152KB
• ex991to13g14118002_103124.htm (EX-99.1) — 11KB
• 0000921895-24-002405.txt ( ) — 165KB

(a). Name of Issuer

Item 1(a). Name of Issuer: Apyx Medical Corporation, a Delaware corporation (the “Issuer”).

(b). Address of Issuer’s Principal Executive Offices

Item 1(b). Address of Issuer’s Principal Executive Offices: 5115 Ulmerton Road, Clearwater, Florida 33760

(a). Name of Person Filing

Item 2(a). Name of Person Filing:

(b). Address of Principal Business Office or, if None, Residence

Item 2(b). Address of Principal Business Office or, if None, Residence:

(c). Citizenship

Item 2(c). Citizenship: Strategos Fund, L.P. (“Strategos”) 1100 19 th Avenue E, Seattle, Washington 98112 Citizenship: Delaware Strategos Master Fund, L.P. (“Strategos Master”) 1100 19 th Avenue E, Seattle, Washington 98112 Citizenship: Cayman Islands Strategos Master Fund GP LLC (“Strategos GP”) 1100 19 th Avenue E, Seattle, Washington 98112 Citizenship: Delaware Archon Capital Management LLC (“Archon”) 1100 19 th Avenue E, Seattle, Washington 98112 Citizenship: Washington Constantinos Christofilis 1100 19 th Avenue E, Seattle, Washington 98112 Citizenship: United States of America

(d). Title of Class of Securities

Item 2(d). Title of Class of Securities: Common Stock, $0.001 par value per share (the “Shares”).

(e). CUSIP Number

Item 2(e). CUSIP Number : 03837C106 7 CUSIP No. 03837C106

If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a

Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: /x/ Not applicable. (a) / / Broker or dealer registered under Section 15 of the Exchange Act. (b) / / Bank as defined in Section 3(a)(6) of the Exchange Act. (c) / / Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) / / Investment company registered under Section 8 of the Investment Company Act. (e) / / An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). (f) / / An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). (g) / / A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G). (h) / / A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) / / A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act. (j) / / Non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J). (k) / / Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

Ownership

Item 4. Ownership. (a) Amount beneficially owned: As of the close of business on October 31, 2024, (i) Strategos beneficially owned 1,794,920 Shares and (ii) Strategos Master beneficially owned 1,320,361 Shares. Strategos GP, as the general partner of Strategos Master, may be deemed to beneficially own the 1,320,361 Shares owned by Strategos Master. Archon, serving as the general partner and investment manager of Strategos and investment manager to Strategos Master, may be deemed to beneficially own the 1,794,920 Shares owned by Strategos and the 1,320,361 Shares owned by Strategos Master. Mr. Christofilis, as the Managing Member of Archon, may be deemed to beneficially own the 1,794,920 Shares owned by Strategos and the 1,320,361 Shares owned by Strategos Master. (b) Percent of class: The following percentages are based on 34,643,926 Shares outstanding, as of August 7, 2024, which is the total number of Shares outstanding as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 8, 2024. 8 CUSIP No. 03837C106 As of the close of business on October 31, 2024, (i) Strategos beneficially owned approximately 5.18% of the outstanding Shares, (ii) Strategos Master beneficially owned 3.81% of the outstanding Shares, (iii) Strategos GP may be deemed to beneficially own approximately 3.81% of the outstanding Shares and (iv) each of Archon and Mr. Christofilis may be deemed to beneficially own approximately 8.99% of the outstanding Shares. (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: See Cover Pages Items 5-9. (ii) Shared power to vote or to direct the vote: See Cover Pages Items 5-9. (iii) Sole power to dispose or to direct the disposition of: See Cover Pages Items 5-9. (iv) Shared power to dispose or to direct the disposition of: See Cover Pages Items 5-9.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class. Not Applicable.

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not Applicable. Item 7. Identification and Classification of the Subsidiary That Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not Applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. See Exhibit 99.1.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not Applicable.

Certifications

Item 10. Certifications. By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 9 CUSIP No. 03837C106 SIGNATURE After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: October 31, 2024 STRATEGOS FUND, L.P. By: Archon Capital Management LLC, its General Partner By: /s/ Constantinos Christofilis Name: Constantinos Christofilis Title: Managing Member STRATEGOS MASTER FUND, L.P. By: Archon Capital Management LLC, its Investment Manager By: /s/ Constantinos Christofilis Name: Constantinos Christofilis Title: Managing Member STRATEGOS MASTER FUND GP LLC By: Archon Capital Management LLC, its Sole Member By: /s/ Constantinos Christofilis Name: Constantinos Christofilis Title: Managing Member ARCHON CAPITAL MANAGEMENT LLC By: /s/ Constantinos Christofilis Name: Constantinos Christofilis Title: Managing Member /s/ Constantinos Christofilis CONSTANTINOS CHRISTOFILIS 10

View Full Filing

View this SC 13G filing on SEC EDGAR